11.1 Principles of Early Tangential vs. Fascial Surgical Excision and Blood Conservation

11.1 Principles of Early Tangential vs. Fascial Surgical Excision and Blood Conservation

Core Knowledge: The surgical management of severe thermal injury has undergone a profound paradigm shift. Modern burn care has abandoned historical "expectant" or delayed debridement—which waited weeks for necrotic eschar to spontaneously slough—in favor of early total surgical excision and immediate wound closure. For the Certified Burn Registered Nurse (CBRN), mastering the physiological rationale, operative techniques, differentiating indications, and aggressive blood conservation strategies of early excision is fundamental to optimizing patient survival and functional recovery.

---

1. The Modern Surgical Paradigm: Early Excision vs. Delayed Debridement

For decades, burn management relied on conservative topical antimicrobial therapy until nonviable eschar separated spontaneously through bacterial collagenase action. This historical approach resulted in prolonged hospitalization, intractable hypermetabolism, devastating burn wound sepsis, and high mortality rates. The pioneering work of Zora Janžekovič in 1970 established early tangential excision as the definitive standard of care.

                      PARADIGM SHIFT IN BURN SURGERY
  ┌────────────────────────────────────────────────────────────────────────┐
  │ HISTORICAL DELAYED DEBRIDEMENT (Obsolete)                             │
  │ • Wait 2–4 weeks for eschar to separate spontaneously via autolysis    │
  │ • Massive bacterial proliferation beneath necrotic tissue              │
  │ • Sustained cytokine storm (TNF-α, IL-1β, IL-6) driving hypermetabolism│
  │ • High incidence of invasive burn wound sepsis, MODS, and mortality    │
  ├────────────────────────────────────────────────────────────────────────┤
  │ MODERN EARLY TOTAL EXCISION (Current Standard of Care)                 │
  │ • Surgical excision within 24 to 72 hours (once hemodynamically stable)│
  │ • Immediate removal of the necrotic pro-inflammatory nidus             │
  │ • Abrupt reduction in systemic inflammatory response syndrome (SIRS)   │
  │ • Immediate permanent autografting or temporary biological coverage    │
  │ • Shortened ICU length of stay, preserved lean body mass, high survival│
  └────────────────────────────────────────────────────────────────────────┘

Timing and Hemodynamic Prerequisites

Early surgical excision is typically initiated within the first 24 to 72 hours post-injury, immediately following the completion of initial fluid resuscitation. Surgical intervention must never precede hemodynamic stabilization. The critical clinical criteria confirming readiness for the operating room include:

• Resolution of Burn Shock: Restoration of adequate end-organ perfusion documented by a urine output of $0.5\text{ to }1.0\text{ mL/kg/hr}$ in adults ($1.0\text{ to }1.5\text{ mL/kg/hr}$ in children).
• Lactate & Base Deficit Normalization: Serum lactate clearance ($<2.0\text{ mmol/L}$) and resolving base deficit ($-2\text{ to }+2\text{ mEq/L}$).
• Hemodynamic Stability: Minimal or weaning vasopressor requirements, with mean arterial pressure (MAP) $\ge 65\text{ mmHg}$.
• Ventilatory Optimization: Manageable peak inspiratory pressures and acceptable oxygenation indices ($PaO_2/FiO_2 > 200$).
• Absence of Uncorrected Coagulopathy: Platelet count $>50,000/\mu\text{L}$, INR $<1.5$, and normal fibrinogen levels ($>150\text{ mg/dL}$).

Multisystem Benefits of Early Eschar Removal

1. Elimination of Sepsis Nidus: Necrotic, avascular eschar provides an ideal culture medium for microbial colonization. Excising this dead tissue before quantitative bacterial counts exceed $10^5\text{ CFU/g}$ halts the transition from surface colonization to invasive burn wound sepsis and angioinvasion.
2. Attenuation of Hypermetabolism: Burn eschar continuously sheds damage-associated molecular patterns (DAMPs) and stimulates massive systemic release of pro-inflammatory cytokines ($TNF-\alpha, IL-1\beta, IL-6$). Early excision abruptly terminates this stimulus, reducing resting energy expenditure (REE), blunting muscle proteolysis, and conserving essential lean body mass.
3. Preservation of Viable Dermis: In deep partial-thickness burns, prompt excision prevents the secondary conversion of the "zone of stasis" into nonviable necrotic tissue (zone of coagulation) caused by local edema, thrombosis, and infection.
4. Reduction in Hospitalization: Every 1% of TBSA excised and successfully closed early reduces ICU length of stay by approximately 1 day.

---

2. Excision Techniques: Tangential vs. Fascial Excision

The burn surgeon selects between two primary surgical modalities—tangential excision and fascial excision—based upon burn depth, total body surface area (TBSA) involved, anatomical location, and the patient's underlying physiological reserve.

                     SURGICAL EXCISION TISSUE PLANES
  
  [ Epidermis ]      ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
  [ Dermis ]         ▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒ ◄── Tangential Excision Plane
  [ Subcut. Fat ]    ▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓     (Viable bleeding tissue)
  ────────────────── ══════════════════════════════════════ ◄── Fascial Excision Plane
  [ Deep Fascia ]    ══════════════════════════════════════     (Deep investing muscle fascia)
  [ Skeletal Muscle] ██████████████████████████████████████

Tangential Excision (Sequential Shaving)

Tangential excision involves the sequential, layer-by-layer shaving of burned tissue using specialized guarded knives or dermatomes until a uniformly healthy, viable recipient bed is exposed.

• Instrumentation: Guarded manual knives such as the Goulian knife or Watson knife (fitted with calibration guards ranging from 0.004 to 0.024 inches), the Humby knife, power dermatomes, or the Versajet hydrosurgery system (which uses a high-velocity saline jet to precisely debride nonviable tissue while sparing viable dermis).
• Visual Endpoints of Viability:
  • In dermal excision: Shaving continues until encountering a uniform, bright, pearly-white dermal bed displaying diffuse, brisk, pinpoint punctate capillary bleeding.
  • In full-thickness/subcutaneous excision: Shaving continues down through nonviable fat until encountering glistening, bright-yellow, lobulated adipose tissue with active microvascular bleeding. Dull, grayish, thrombosed, or dry fat must be excised completely, as skin grafts will not survive on nonviable or avascular adipose tissue.
• Advantages: Preserves subcutaneous fat architecture, maintains normal body contours, preserves joint mobility and functional gliding planes, and delivers superior long-term aesthetic outcomes. It is the gold standard for the face, neck, hands, feet, and joints.
• Disadvantages & Risks: Associated with massive operative blood loss (frequently estimated at $0.5\text{ to }1.0\text{ mL of blood per cm}^2$ of tissue excised, or $2.0\text{ to }3.0\text{ mL of blood per }1%\text{ TBSA excised}$). Prolonged tangential shaving in extensive burns can precipitate severe hypovolemic shock, coagulopathy, and hypothermia.

Fascial Excision (Radical Excision)

Fascial excision involves the radical en bloc resection of the entire burned skin envelope and underlying subcutaneous adipose tissue down to the deep investing muscular fascia using electrocautery.

• Technique: The incision is carried through the skin and subcutaneous fat directly to the glistening white, fibrous muscle fascia. The entire tissue layer is stripped off the muscle fascia using monopolar electrocautery or cutting shears.
• Indications:
  • Massive burn injuries ($>50\text{–}60%\text{ TBSA}$) where rapid excision is mandatory and donor skin/blood bank reserves are scarce.
  • Invasive, life-threatening burn wound sepsis or necrotizing soft tissue infection with angioinvasion extending into the subcutaneous space.
  • Deep fourth-degree burns involving the subcutaneous tissue, fat necrosis, or deep electrical injuries.
  • Physiologically exhausted, critically ill, or elderly patients who cannot tolerate the severe blood loss and protracted operative times of tangential excision.
• Advantages: Exceptionally fast, achieves near-complete hemostasis with minimal blood loss (often $<0.1\text{ to }0.2\text{ mL/cm}^2$), and provides an uninfected, highly vascular fascial bed that yields near 100% skin graft take.
• Disadvantages & Deformities:
  • Severe Cosmetic Deformity: Results in a permanent "skeletonized" or hollowed-out contour deformity due to the total loss of the subcutaneous fat layer.
  • Joint Stiffness & Tethering: Grafts placed directly on fascia adhere rigidly, losing normal tissue compliance and predisposing to severe contractures across mobile planes.
  • Chronic Distal Lymphedema: Radical excision severs all superficial subdermal and subcutaneous lymphatic channels and cutaneous veins, leading to intractable, lifelong dependent edema in the extremities.
  • Loss of Protective Sensation: Complete transection of cutaneous nerves leads to permanent anesthesia.

Comparative Analysis: Tangential vs. Fascial Excision

---

3. Comprehensive Operative Blood Conservation Strategies

Intraoperative hemorrhage during extensive tangential excision represents one of the greatest threats to the critically ill burn patient. Uncontrolled blood loss triggers the "lethal triad" of trauma: hypothermia, metabolic acidosis, and coagulopathy. A proactive, multimodal blood conservation protocol must be executed before, during, and after surgical debridement.

                    MULTIMODAL BLOOD CONSERVATION BUNDLE
  ┌────────────────────────────────────────────────────────────────────────┐
  │ [1] PRE-INCISION: Tumescent Subcutaneous Clysis                        │
  │     • Infiltrate epinephrine 1:500,000–1:1,000,000 in LR/saline        │
  │     • Induces intense microvascular vasoconstriction for 30–60 minutes │
  ├────────────────────────────────────────────────────────────────────────┤
  │ [2] MECHANICAL HEMOSTASIS: Extremity Tourniquets                       │
  │     • Exsanguinate limb with Esmarch bandage                           │
  │     • Inflate pneumatic cuff (Upper: 200–250 mmHg; Lower: 250–300 mmHg)│
  │     • Complete excision and grafting in a bloodless field (<90–120 min)│
  ├────────────────────────────────────────────────────────────────────────┤
  │ [3] TOPICAL HEMOSTATIC AGENTS & COMPRESSION                            │
  │     • Apply topical thrombin (5,000–10,000 units/vial) or epi-sponges  │
  │     • Compress wound bed with warm laparotomy pads for 5–10 minutes    │
  │     • Fibrin sealants (Tisseel) and oxidized regenerated cellulose     │
  ├────────────────────────────────────────────────────────────────────────┤
  │ [4] SYSTEMIC PHARMACOTHERAPY: Antifibrinolytics                        │
  │     • Tranexamic Acid (TXA): 10–15 mg/kg IV bolus, then 1–5 mg/kg/hr   │
  │     • Competitively inhibits plasminogen activation to prevent lysis   │
  ├────────────────────────────────────────────────────────────────────────┤
  │ [5] SURGICAL PLANNING & BLOOD SALVAGE                                  │
  │     • Limit single-stage excision to ≤15–20% TBSA or ≤2 hours OR time │
  │     • Intraoperative Cell Saver (washed autologous red cell salvage)   │
  └────────────────────────────────────────────────────────────────────────┘

1. Tumescent Clysis (Subcutaneous Epinephrine Infiltration)

Prior to surgical incision or dermatome shaving, the surgical team infiltrates the subcutaneous plane beneath the burn eschar with a dilute epinephrine solution:

• Formulation: Epinephrine $1:500,000\text{ to }1:1,000,000$ concentration dissolved in Lactated Ringer's or normal saline (e.g., 1 mg of epinephrine in 1,000 mL of crystalloid $= 1:1,000,000$).
• Administration: Infiltrated using a multi-hole clysis needle or peristaltic infiltration pump until the tissue becomes firm and turgid.
• Physiological Action: Epinephrine stimulates $\alpha_1$-adrenergic receptors on cutaneous arterioles and venules, producing intense vasoconstriction. This reduces operative blood loss by 50% to 75% during tangential shaving.
• Nursing & Anesthesia Precautions: Monitor continuously for transient tachycardia, hypertension, and cardiac dysrhythmias following infiltration. Systemic absorption is heightened in pediatric patients; total epinephrine dosing must not exceed toxic thresholds ($<0.1\text{ mg/kg}$ in dilute form).

2. Extremity Tourniquets

For burn excision and grafting localized to the upper and lower extremities, pneumatic tourniquets provide a completely bloodless surgical field:

• Application: The extremity is elevated and exsanguinated using an elastic Esmarch bandage. The pneumatic tourniquet is inflated to 200–250 mmHg on the upper extremity (or $50\text{–}100\text{ mmHg}$ above systolic blood pressure) and 250–300 mmHg on the lower extremity.
• Excision and Grafting Protocol: The surgeon rapidly excises the eschar, prepares the recipient bed, and secures the skin graft or biological dressing entirely under tourniquet control. A compressive bolster dressing is applied before tourniquet deflation to mechanically suppress reactive hyperemic bleeding.
• Tourniquet Safety Limits: Inflation time must not exceed 90 to 120 minutes to prevent ischemic neuromuscular injury, nerve palsies, and reperfusion compartment syndrome. If surgery exceeds 2 hours, the cuff must be deflated for 15–20 minutes to allow limb reperfusion.

3. Topical Hemostatic Adjuncts

Following tangential shaving, raw, oozing capillary beds are treated with topical hemostatic agents under firm compression:

• Topical Epinephrine Soaked Gauze: Sponges soaked in epinephrine $1:10,000\text{ to }1:100,000$ solution applied under manual pressure for 5–10 minutes.
• Topical Bovine or Human Thrombin: Sprayed or applied via thrombin-soaked gelatin sponges (5,000 to 20,000 units). Thrombin converts host fibrinogen directly into an insoluble fibrin clot, bypassing early coagulation cascade defects.
• Fibrin Sealants (e.g., Tisseel, Artiss): Contain concentrated human fibrinogen and thrombin. Used to fix skin grafts to the recipient bed while simultaneously securing microvascular hemostasis.

4. Pharmacological Antifibrinolytics: Tranexamic Acid (TXA)

Tranexamic Acid (TXA) is a synthetic lysine analog that competitively blocks the lysine-binding sites on plasminogen molecules, halting its conversion to plasmin. This prevents fibrin clot degradation (fibrinolysis) in the microvascular wound bed.

• Dosing Protocol: Administered as an IV loading dose of 10 to 15 mg/kg over 20 minutes prior to surgical incision, followed by a continuous infusion of 1 to 5 mg/kg/hr throughout the operative case.
• Evidence: Randomized controlled trials in burn surgery demonstrate that TXA reduces perioperative packed red blood cell (PRBC) transfusion requirements by 30% to 40% without increasing the incidence of deep vein thrombosis (DVT) or pulmonary embolism (PE).

---

4. Maintenance of Intraoperative Normothermia

Burn patients possess impaired thermoregulatory capacity due to the loss of the epidermal barrier, extensive evaporative heat loss, and cold operating room environments. Intraoperative hypothermia (core temperature $<35.0^\circ\text{C}$ or $<95.0^\circ\text{F}$) is catastrophic:

• Coagulopathy: For every $1.0^\circ\text{C}$ drop in core body temperature, clotting factor enzyme activity declines by approximately 10%, and platelet aggregation/adhesion is profoundly inhibited, leading to uncontrollable microvascular hemorrhage.
• Cardiac Dysrhythmias & Acidosis: Hypothermia induces peripheral vasoconstriction, worsening metabolic acidosis and precipitating ventricular arrhythmias.

Nursing and Environmental Protocols for Thermal Protection

1. Elevated Ambient OR Temperature: The operating room ambient temperature must be pre-warmed and maintained between $28.0^\circ\text{C}\text{ and }32.0^\circ\text{C}$ ($82.4^\circ\text{F}\text{ to }89.6^\circ\text{F}$) before the patient arrives.
2. Active External Warming Devices: Utilize forced-air warming blankets (e.g., Bair Hugger) placed over uninjured anatomical regions, under-body circulating-water warming mattresses, and overhead radiant warmers.
3. Fluid and Blood Warming: All intravenous crystalloid resuscitation fluids, packed red blood cells, fresh frozen plasma, and surgical irrigation solutions must be actively warmed to $37.0^\circ\text{C}\text{ to }40.0^\circ\text{C}$ using rapid in-line fluid warmers.
4. Limiting Exposure & Staging Procedures: Expose only the specific anatomical area being actively prepped and excised; keep the remainder of the body covered with dry, warm drapes. Single-stage surgical excision should be restricted to $\le 15%\text{ to }20%\text{ TBSA}$ or a maximum operative duration of 2 hours to avoid hypothermia and hemodynamic collapse.